Viral modulation of cellular RNA alternative splicing: A new key player in virus-host interactions?


Journal

Wiley interdisciplinary reviews. RNA
ISSN: 1757-7012
Titre abrégé: Wiley Interdiscip Rev RNA
Pays: United States
ID NLM: 101536955

Informations de publication

Date de publication:
09 2019
Historique:
received: 13 12 2018
revised: 25 03 2019
accepted: 08 04 2019
pubmed: 30 4 2019
medline: 15 7 2020
entrez: 30 4 2019
Statut: ppublish

Résumé

Upon viral infection, a tug of war is triggered between host cells and viruses to maintain/gain control of vital cellular functions, the result of which will ultimately dictate the fate of the host cell. Among these essential cellular functions, alternative splicing (AS) is an important RNA maturation step that allows exons, or parts of exons, and introns to be retained in mature transcripts, thereby expanding proteome diversity and function. AS is widespread in higher eukaryotes, as it is estimated that nearly all genes in humans are alternatively spliced. Recent evidence has shown that upon infection by numerous viruses, the AS landscape of host-cells is affected. In this review, we summarize recent advances in our understanding of how virus infection impacts the AS of cellular transcripts. We also present various molecular mechanisms allowing viruses to modulate cellular AS. Finally, the functional consequences of these changes in the RNA splicing signatures during virus-host interactions are discussed. This article is categorized under: RNA in Disease and Development > RNA in Disease RNA Processing > Splicing Regulation/Alternative Splicing.

Identifiants

pubmed: 31034770
doi: 10.1002/wrna.1543
pmc: PMC6767064
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1543

Subventions

Organisme : CIHR
Pays : Canada

Informations de copyright

© 2019 The Authors. WIREs RNA published by Wiley Periodicals, Inc.

Références

PLoS One. 2013 Sep 16;8(9):e73723
pubmed: 24066065
Virology. 2015 Sep;483:229-35
pubmed: 25985441
Viruses. 2018 Sep 17;10(9):
pubmed: 30227597
J Virol. 2008 Jul;82(14):7180-8
pubmed: 18463151
Blood. 2005 May 15;105(10):3987-94
pubmed: 15665117
PLoS Negl Trop Dis. 2013;7(3):e2107
pubmed: 23516652
Mol Immunol. 1999 Jul;36(10):647-58
pubmed: 10509816
J Virol. 2004 Oct;78(19):10598-605
pubmed: 15367627
J Virol. 1995 Oct;69(10):6063-76
pubmed: 7666511
EMBO Rep. 2002 Nov;3(11):1088-93
pubmed: 12393754
Trends Microbiol. 2019 Mar;27(3):268-281
pubmed: 30577974
J Virol. 1998 Oct;72(10):8354-7
pubmed: 9733883
PLoS One. 2016 Sep 06;11(9):e0161914
pubmed: 27598998
BMC Genomics. 2017 Nov 25;18(1):911
pubmed: 29178824
Mol Ther Nucleic Acids. 2019 Mar 1;14:251-261
pubmed: 30641477
J Virol. 2014 Nov;88(21):12599-611
pubmed: 25142587
J Virol. 2001 May;75(9):4376-85
pubmed: 11287586
Genes Dev. 1992 May;6(5):848-63
pubmed: 1315705
Virology. 2002 Mar 1;294(1):189-98
pubmed: 11886277
BMC Res Notes. 2008 Oct 24;1:94
pubmed: 18950505
PLoS One. 2017 May 11;12(5):e0176880
pubmed: 28493890
Oncogene. 2016 May 12;35(19):2465-74
pubmed: 26257065
Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):9056-60
pubmed: 8415652
J Virol. 2013 Nov;87(22):12291-301
pubmed: 24027308
Infect Agents Dis. 1994 Apr-Jun;3(2-3):59-67
pubmed: 7812656
Curr Top Microbiol Immunol. 2007;316:233-50
pubmed: 17969451
Biochem Soc Trans. 2012 Aug;40(4):773-7
pubmed: 22817732
Nat Struct Mol Biol. 2016 Dec;23(12):1101-1110
pubmed: 27775709
J Virol. 2009 Mar;83(5):2178-87
pubmed: 19109390
J Virol. 2018 Jul 17;92(15):
pubmed: 29769336
RNA. 2012 Nov;18(11):2073-82
pubmed: 23012480
EMBO J. 2003 Apr 1;22(7):1608-19
pubmed: 12660167
J Virol. 2017 Mar 13;91(7):
pubmed: 28077658
J Virol. 2009 Jan;83(2):770-80
pubmed: 19004954
Nucleic Acids Res. 2017 Apr 20;45(7):4051-4067
pubmed: 27928057
Virol J. 2019 Mar 4;16(1):29
pubmed: 30832682
Cell Rep. 2013 Nov 27;5(4):909-17
pubmed: 24210824
BMC Genomics. 2016 Aug 11;17(1):613
pubmed: 27515794
RNA. 1995 May;1(3):304-16
pubmed: 7489502
Biomed Rep. 2015 Mar;3(2):152-158
pubmed: 25798239
J Biol Chem. 2009 Nov 6;284(45):31350-62
pubmed: 19737937
Genes Dev. 1994 Aug 1;8(15):1817-28
pubmed: 7958859
Biochem Soc Trans. 2005 Jun;33(Pt 3):499-501
pubmed: 15916551
J Gen Virol. 1999 May;80 ( Pt 5):1311-1316
pubmed: 10355778
FEBS Lett. 2016 Dec;590(24):4594-4605
pubmed: 27859058
Virology. 2012 Mar 30;425(1):40-52
pubmed: 22280896
J Gen Virol. 1995 Apr;76 ( Pt 4):1001-7
pubmed: 9049349
J Biol Chem. 2015 Dec 25;290(52):30931-46
pubmed: 26534959
PLoS One. 2014 Mar 14;9(3):e91745
pubmed: 24633222
J Virol. 2002 May;76(9):4483-96
pubmed: 11932414
Wiley Interdiscip Rev RNA. 2019 Sep;10(5):e1543
pubmed: 31034770
Prog Mol Biol Transl Sci. 2016;142:241-68
pubmed: 27571697
J Virol. 2009 Apr;83(7):2892-906
pubmed: 19176625
J Clin Invest. 2012 May;122(5):1667-76
pubmed: 22523064
J Proteome Res. 2018 Apr 6;17(4):1474-1484
pubmed: 29558158
Retrovirology. 2014 Dec 18;11:119
pubmed: 25519886
J Virol. 2015 Nov;89(22):11356-71
pubmed: 26339049
Sci Rep. 2016 Jun 29;6:28075
pubmed: 27354008
Nature. 2008 Nov 27;456(7221):470-6
pubmed: 18978772
Nucleic Acids Res. 2009 Oct;37(19):6515-27
pubmed: 19729513
Front Biosci. 2008 May 01;13:5241-56
pubmed: 18508584
Biochem Soc Trans. 2006 Dec;34(Pt 6):1145-7
pubmed: 17073771
J Hepatol. 2015 May;62(5):1024-32
pubmed: 25481564
Mol Immunol. 1998 Dec;35(18):1189-206
pubmed: 10199393
Plant Cell. 2015 Jan;27(1):71-85
pubmed: 25634987
J Proteome Res. 2016 May 6;15(5):1639-48
pubmed: 27096427
Front Microbiol. 2018 Sep 12;9:2192
pubmed: 30258431
J Gen Virol. 2011 Jun;92(Pt 6):1273-1278
pubmed: 21325479
PLoS Pathog. 2018 Aug 24;14(8):e1007277
pubmed: 30142213
Nat Commun. 2018 Jun 19;9(1):2407
pubmed: 29921878
Annu Rev Virol. 2015 Nov;2(1):549-72
pubmed: 26958928
J Virol. 2018 Aug 16;92(17):
pubmed: 29976658
BMC Genomics. 2016 Aug 26;17:683
pubmed: 27565572
Genes Cells. 2012 Jul;17(7):525-35
pubmed: 22672474
J Hepatol. 2012 Feb;56(2):326-33
pubmed: 21888876
J Virol. 2018 Sep 26;92(20):
pubmed: 30068640
Virol J. 2017 Nov 7;14(1):217
pubmed: 29116029
PLoS Pathog. 2014 Jun 26;10(6):e1004199
pubmed: 24968230
J Virol. 2015 Jul;89(14):7064-78
pubmed: 25926642
Virus Res. 2015 May 4;203:84-91
pubmed: 25865411
FEBS J. 2011 Sep;278(18):3246-55
pubmed: 21794093
EMBO J. 1994 Feb 1;13(3):704-12
pubmed: 8313914
PLoS Pathog. 2016 Aug 30;12(8):e1005841
pubmed: 27575636
Biochem Soc Trans. 2010 Aug;38(4):1116-21
pubmed: 20659014
Biochem Biophys Res Commun. 2011 Oct 14;414(1):142-7
pubmed: 21945619
Annu Rev Biochem. 2015;84:291-323
pubmed: 25784052
PLoS One. 2015 Jun 29;10(6):e0124638
pubmed: 26121143
Virol J. 2015 Feb 06;12:14
pubmed: 25890165
J Biol Chem. 2004 Jun 25;279(26):27699-708
pubmed: 15082713
J Virol. 2010 Nov;84(22):11781-9
pubmed: 20810723
Avian Pathol. 2018 Dec;47(6):585-594
pubmed: 30101593
Genes Dev. 2010 Nov 1;24(21):2343-64
pubmed: 21041405
Nat Rev Mol Cell Biol. 2004 Sep;5(9):727-38
pubmed: 15340380
J Virol. 2017 May 12;91(11):
pubmed: 28331096
Gene. 2018 Aug 5;666:123-133
pubmed: 29730427
J Virol. 1985 Sep;55(3):796-805
pubmed: 2991596
J Biol Chem. 2004 Apr 30;279(18):18497-503
pubmed: 14978041
Sci Rep. 2018 Mar 22;8(1):5074
pubmed: 29568077
J Biol Chem. 2012 Oct 19;287(43):36229-38
pubmed: 22915590
J Mol Biol. 2019 Apr 5;431(8):1565-1575
pubmed: 30857970
Microbes Infect. 2007 Apr;9(4):490-7
pubmed: 17347016
Cell. 1977 Sep;12(1):1-8
pubmed: 902310
J Virol. 2008 Mar;82(6):2792-801
pubmed: 18184716
Microbes Infect. 2005 Jul;7(9-10):1150-60
pubmed: 15908254
J Virol. 2012 Feb;86(4):2302-11
pubmed: 22156521
EMBO J. 2001 Feb 15;20(4):864-71
pubmed: 11179230
J Virol. 2009 Jan;83(1):357-67
pubmed: 18945764
Wiley Interdiscip Rev RNA. 2017 Nov;8(6):
pubmed: 28815931
J Virol. 2016 Apr 29;90(10):5047-58
pubmed: 26962216
J Virol. 2013 Mar;87(5):2390-400
pubmed: 23255796
J Virol. 2019 Mar 21;93(7):
pubmed: 30651364
Wiley Interdiscip Rev RNA. 2014 Mar-Apr;5(2):223-30
pubmed: 24190870
Nature. 1998 May 14;393(6681):185-7
pubmed: 9603524
Immunol Cell Biol. 2011 Feb;89(2):173-82
pubmed: 20603636
J Virol. 2014 Oct;88(19):11586-99
pubmed: 25078689
Brief Funct Genomic Proteomic. 2002 Oct;1(3):266-77
pubmed: 15239893
Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11329-33
pubmed: 16840555
PLoS One. 2015 Jun 19;10(6):e0131137
pubmed: 26091335
Methods. 1998 Sep;16(1):95-104
pubmed: 9774519
J Pathol. 2009 Nov;219(3):383-91
pubmed: 19718710
Virology. 2007 Oct 10;367(1):212-21
pubmed: 17561226
Methods Mol Biol. 2014;1126:83-96
pubmed: 24549657
J Clin Invest. 2012 May;122(5):1653-66
pubmed: 22523069
Virus Res. 2018 Mar 2;247:40-46
pubmed: 29382551
Bioessays. 2008 Jan;30(1):38-47
pubmed: 18081010
Retrovirology. 2008 Feb 04;5:18
pubmed: 18241354
J Virol. 2019 Feb 19;93(5):
pubmed: 30541862
J Gen Virol. 2004 Dec;85(Pt 12):3541-3553
pubmed: 15557227
J Virol. 1994 Dec;68(12):7790-9
pubmed: 7966568
Proc Natl Acad Sci U S A. 1977 Aug;74(8):3171-5
pubmed: 269380

Auteurs

Simon Boudreault (S)

Département de biochimie, Faculté de médecine et des sciences de la santé, Université de Sherbrooke, Sherbrooke, Québec, Canada.

Patricia Roy (P)

Département de biochimie, Faculté de médecine et des sciences de la santé, Université de Sherbrooke, Sherbrooke, Québec, Canada.

Guy Lemay (G)

Département de microbiologie, infectiologie et immunologie, Faculté de médecine, Université de Montréal, Montréal, Québec, Canada.

Martin Bisaillon (M)

Département de biochimie, Faculté de médecine et des sciences de la santé, Université de Sherbrooke, Sherbrooke, Québec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH